top of page
IQ MPS
IQ Microphysiological Systems Affiliate
An Affiliate of the International Consortium for Innovation and Quality in Drug Development
Projects
The IQ MPS Affiliate offers a range of opportunities to collaborate with industry leaders in advancing the application of microphysiological systems (MPS) in drug development. These include targeted requests to evaluate platform performance, as well as interactive forums that foster scientific exchange, feedback, and professional growth. Check back regularly to see our current opportunities.
Gastrointestinal Microphysiological System Testing for Specific Contexts of Use in Drug Development - RFI & RFP CLOSED
The IQ MPS Affiliate seeks novel gastrointestinal MPS technology platforms with clear, mechanistically-based rationale that not only recapitulate the human intestinal environment in terms of functional capabilities, but also demonstrate improved clinical predictivity for key ADME endpoints and toxicological responses. A single model that addresses all responses, while desirable, is not the sole objective. Emphasis on endpoint-specific predictivity of clinical responses and proven utility will be the most critical for potential future adoption of these systems in drug discovery and development.
Download the RFI here.
Kidney Microphysiological System Testing for Specific Contexts of Use in Drug Development - RFI & RFP CLOSED
The IQ MPS Affiliate seeks novel kidney MPS technology platforms with clear, mechanistically-based rationale that not only recapitulate the human renal environment in terms of functional capabilities, but also demonstrate improved clinical predictivity for key ADME endpoints and toxicological responses. A single model that addresses all responses, while desirable, is not the sole objective. Emphasis on endpoint-specific predictivity of clinical response and proven utility will be most critical for potential future adoption of these systems in drug discovery and development.
Download the RFI here.
bottom of page